A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers
NCT01755247
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
Topical Gel Vehicle
DRUG:
8% NVN1000 Topical Gel
DRUG:
8% NVN1000 Topical Gel and moisturizer
Sponsor
Novan, Inc.